NICE celebrates its 20th anniversary
Organisation was founded in April 1999 to improve outcome for health service users
Latest news headlines
NICE says drug to treat Batten disease cannot be recommended for NHS use because company is unable to address concerns about long-term effectiveness
NICE has published draft guidance which confirms its earlier decision not to recommend cerliponase alfa (also called Brineura and made by Biomarin) for children with Batten disease – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.
22 February 2019
Shared Learning Awards: Judges reveal 20 shortlisted entries to be displayed at NICE annual conference
More than 60 entries received from organisations across the country which highlight how they put NICE guidance into practice
21 February 2019
NICE draft guidance recommends pertuzumab for new breast cancer indication after improved price offer from company
NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.
15 February 2019
The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided its first piece of advice on the design of a patient preference study.
14 February 2019
People showing erythema migrans, the characteristic skin rash associated with Lyme disease, can be diagnosed without the need for blood tests, NICE says in new guidance.
12 February 2019
NICE and Public Health England publish new antibiotic prescribing guidance for patients with suspected pneumonia
These two guidelines set out an antimicrobial prescribing strategy that aims to optimise antibiotic use and reduce antibiotic resistance.
12 February 2019